ArticleJournal of the American Geriatrics Society2017
Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.
Article in Journal of the American Geriatrics Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.Journal of healthcare engineering · 2022Pooled it
- Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review.Journal of Alzheimer's disease : JAD · 2019Pooled it
- Association of sociodemographic factors and comorbidity with non-receipt of medications for secondary prevention: a cohort study of 12,204 myocardial infarction survivors.BMC medicine · 2025Article
- Prescription Fills Among Patients With Type 2 Diabetes After Hospitalization for Acute Coronary Syndrome.JAMA network open · 2024Article
- Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease.Journal of the American Geriatrics Society · 2023Article
- Association between sociodemographic factors and cholesterol-lowering medication use in U.S. adults post-myocardial infarction.PloS one · 2023Article
- Use of health and aged care services in Australia following hospital admission for myocardial infarction, stroke or heart failure.BMC geriatrics · 2021Article
- Underprescription of medications in older adults: causes, consequences and solutions-a narrative review.European geriatric medicine · 2021Review
- National Trends in Statin Use among the United States Nursing Home Population (2011-2016).Drugs & aging · 2021Article
- Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease.Journal of the American Geriatrics Society · 2021Article
- Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents.Journal of the American Medical Directors Association · 2021Article
- Article
- Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents.Journal of the American Medical Directors Association · 2020Article
- Patient-Important Adverse Events of β-blockers in Frail Older Adults after Acute Myocardial Infarction.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019Article
- Change in Prescribing for Secondary Prevention of Stroke and Coronary Heart Disease in Finnish Nursing Homes and Assisted Living Facilities.Drugs & aging · 2019Article
- Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.Journal of the American Heart Association · 2019Observational
- Association Between Secondary Prevention Medication Use and Outcomes in Frail Older Adults After Acute Myocardial Infarction.Circulation. Cardiovascular quality and outcomes · 2019Observational
- Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction.Diabetes, obesity & metabolism · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
BACKGROUND/
objectivesSecondary prevention medications are recommended for older adults after acute myocardial infarction (AMI), but little is known about whether nursing home (NH) residents receive these medications. The objective was to evaluate new use of secondary prevention medications after AMI in NH residents who were previously nonusers and to evaluate what factors were associated with use.
designRetrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims.
settingU.S. NHs.
participantsNational cohort of 11,192 NH residents aged 65 and older who were hospitalized for an AMI between May 2007 and March 2010, had no beta-blocker or statin use for 4 months or longer before the hospitalization, and survived 14 days or more after NH readmission. MEASUREMENTS: The outcome was the number of secondary prevention medications initiated within 30 days of NH readmission.
resultsThirty-seven percent of residents had no secondary prevention medications initiated after AMI, 41% had 1 initiated, and 22% had 2 initiated. After covariate adjustment, fewer secondary prevention medications were used in older residents (proportional odds ratio (POR) = 0.48, 95% confidence interval (CI) = 0.40-0.57 for ≥95 vs 65-74); women (POR = 0.88, 95% CI = 0.80-0.96);and those with a do-not-resuscitate (DNR) order (POR = 0.90, 95% CI = 0.83-0.98), functional impairment (dependent or totally dependent vs independent to limited assistance, POR = 0.77, 95% CI = 0.69-0.86), and cognitive impairment (moderate to severe vs no impairment, POR = 0.79, 95% CI = 0.70-0.89).
conclusionMore than one-third of older NH residents in the United States do not have any secondary prevention medications initiated after AMI, with fewer medications initiated in older residents; women; and those with, DNR orders, poor physical function, and cognitive impairment. A lack of evidence about the safety and effectiveness of secondary preventions medications in the NH population and unmeasured person-centered goals of care are plausible explanations for these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.